CoChat

Current advances in niosomes applications for drug delivery and cancer treatment

Open access
Moammeri, Ali, Chegeni, Masoumeh Mirzaei, Sahrayi, Hamidreza, Ghafelehbashi, Robabehbeygom, Memarzadeh, Farkhondeh, Mansouri, Afsoun, Akbarzadeh, Iman, Abtahi, Maryam Sadat, Hejabi, Faranak, Ren, Qun · 2023 · Materials Today Bio
Cited by 195

The DOI matches its Crossref record; 7 of the 7 references it cites were found in a registry or an index.

Abstract

The advent of nanotechnology has led to an increase in interest in nanocarriers as a delivery system for drugs that is efficient and safe. There have been many studies addressing nano-scale vesicular systems such as liposomes but niosome is a newer generation of vesicular nanocarriers. The niosomes provide a multilamellar carrier for lipophilic and hydrophilic bioactive substances in the self-assembled vesicle, which are composed of non-ionic surfactants in conjunction with cholesterol or other amphiphilic molecules. Non-ionic surfactant vesicles, simply known as niosomes, can be utilized in a wide variety of technological applications. In addition to accommodating both water-soluble and lipid-soluble drug molecules, niosomes may also serve as a versatile device for a variety of applications. As an alternative to liposomes, niosomes can be considered more economically, chemically, and physically stable. There are simple methods of preparing niosomes that can be used in pharmaceutical technology, and the methods can be based on widely used surfactants. Many reports have discussed niosomes in terms of their physicochemical properties and applications as drug delivery systems. As drug carriers, nano-sized niosomes expand the horizons of pharmacokinetics, decreasing toxicity, enhancing drug solvability and bioavailability, reducing fabrication costs, and increasing storage stability. In this review, we discuss the components and fabrication methods of niosomes, as well as their functionalization, characterization, administration routes, and applications in cancer, gene delivery, and natural product delivery, limitations and challenges in the development of niosomes, niosome and other nanocarriers, the future perspective of niosome.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1016/j.mtbio.2023.100837

Cites

7 of 7 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 7 references

Metadata

Authors
Moammeri, A., Chegeni, M. M., Sahrayi, H., Ghafelehbashi, R., Memarzadeh, F., Mansouri, A., Akbarzadeh, I., Abtahi, M. S., Hejabi, F., & Ren, Q.
Venue
Materials Today Bio
Publisher
Elsevier BV
Published
2023-12
Volume
23
Pages
100837
ISSN
2590-0064 (ISSN-L)
OpenAlex
W4387849811
Cited by
195
References
7
FWCI
10.73
Type
journal article
Language
en
Open access
gold

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Current advances in niosomes applications for drug delivery and cancer treatment. https://app.cochat.ai/papers/10.1016/j.mtbio.2023.100837
The paper
Moammeri, A., Chegeni, M. M., Sahrayi, H., Ghafelehbashi, R., Memarzadeh, F., Mansouri, A., Akbarzadeh, I., Abtahi, M. S., Hejabi, F., & Ren, Q. (2023). Current advances in niosomes applications for drug delivery and cancer treatment. Materials Today Bio. https://doi.org/10.1016/j.mtbio.2023.100837

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.